<?xml version="1.0" encoding="UTF-8"?><rss version="2.0">
	<channel>
		<title>(주)프로톡스 Protox Inc.</title>
		<link>http://iprotox.co.kr</link>
		<description></description>
		
				<item>
			<title><![CDATA[인도네시아 독점 파트너십 계약 체결]]></title>
			<link><![CDATA[http://iprotox.co.kr/?kboard_content_redirect=15]]></link>
			<description><![CDATA[㈜프로톡스는 보툴리눔 톡신 A형 제품에 대하여 2026년 3월 6일 인도네시아 현지기업인 PT Sydna Farma 및 HAJU MEDICAL과 독점 파트너십 계약을 체결하였습니다.

PT Sydna Farma는 에스테틱 및 의료기기 유통 전문 기업으로 현지 허가 확보 및 클리닉 기반 B2B 채널을 통해 시장 확대를 담당하며, HAJU MEDICAL은 현지 의료 및 에스테틱 시장에서의 경험 및 역량과 의료기관 네트워크를 기반으로 영업·마케팅을 수행하여 제품의 시장 진입 및 확산을 추진할 예정입니다.

이번 계약을 통해 3사는 인도네시아 시장 진출을 위한 전략적 협력 체계를 구축하게 되었으며, 당사의 제품이 인도네시아 시장에 안정적으로 진입하고 확대될 수 있도록 협력할 계획입니다.

프로톡스는 이번 계약을 포함하여 현재까지 총 52개국에서 독점 파트너십 계약을 체결하며 글로벌 사업 확장을 지속하고 있습니다.

⦁ Contract Overview

<img src="http://iprotox.co.kr/wp-content/uploads/kboard_attached/1/202604/69e86359b360c1990809.png" alt="" width="927" height="228" />

 

2026년 4월 22일

㈜프로톡스]]></description>
			<author><![CDATA[protox]]></author>
			<pubDate>Wed, 22 Apr 2026 05:59:34 +0000</pubDate>
			<category domain="http://iprotox.co.kr/?kboard_redirect=1"><![CDATA[공지사항]]></category>
		</item>
				<item>
			<title><![CDATA[Exclusive Partnership Agreement in Indonesia]]></title>
			<link><![CDATA[http://iprotox.co.kr/?kboard_content_redirect=14]]></link>
			<description><![CDATA[PROTOX Inc. has entered into an Exclusive Partnership Agreement for its Botulinum Toxin Type A product on March 6, 2026, with local Indonesian companies, PT Sydna Farma and HAJU MEDICAL.

PT Sydna Farma is a specialized distributor of aesthetic and medical device products, responsible for securing local regulatory approvals and driving market expansion through its clinic-based B2B channels. HAJU MEDICAL will support market entry and product expansion by carrying out sales and marketing activities, leveraging its experience and capabilities in the local medical and aesthetic market as well as its network of medical institutions.

Through this agreement, the three parties have established a strategic collaboration framework for entry into the Indonesian market and will work closely to ensure the successful launch and expansion of our products.

Including this agreement, PROTOX has established Exclusive Partnership Agreements across a total of 52 countries, and continues to expand its global business footprint.

⦁ Contract Overview

<img src="http://iprotox.co.kr/wp-content/uploads/kboard_attached/2/202604/69e861cc230b13614731.png" alt="" width="854" height="210" />

 

April 22, 2026

PROTOX Inc.]]></description>
			<author><![CDATA[protox]]></author>
			<pubDate>Wed, 22 Apr 2026 05:51:57 +0000</pubDate>
			<category domain="http://iprotox.co.kr/?kboard_redirect=2"><![CDATA[공지사항-en]]></category>
		</item>
				<item>
			<title><![CDATA[Marketing Authorization Granted for PROTOX Injection]]></title>
			<link><![CDATA[http://iprotox.co.kr/?kboard_content_redirect=13]]></link>
			<description><![CDATA[1. Product Name: Protoxin Injection. 100U

2. Marketing Authorization Details
- Approval Date: November 14, 2025
- Regulatory Authority: Ministry of Food and Drug Safety (MFDS), Republic of Korea]]></description>
			<author><![CDATA[protox]]></author>
			<pubDate>Mon, 17 Nov 2025 03:45:45 +0000</pubDate>
			<category domain="http://iprotox.co.kr/?kboard_redirect=2"><![CDATA[공지사항-en]]></category>
		</item>
				<item>
			<title><![CDATA[프로톡신주 생물의약품 품목허가 승인]]></title>
			<link><![CDATA[http://iprotox.co.kr/?kboard_content_redirect=12]]></link>
			<description><![CDATA[1. 품목명 : 프로톡신주 100U

2. 품목허가 승인일 및 허가기관
- 신청일 : 2025년 11월 14일
- 품목허가기관 : 식품의약품안전처(MFDS)]]></description>
			<author><![CDATA[protox]]></author>
			<pubDate>Mon, 17 Nov 2025 03:37:11 +0000</pubDate>
			<category domain="http://iprotox.co.kr/?kboard_redirect=1"><![CDATA[공지사항]]></category>
		</item>
				<item>
			<title><![CDATA[주주총회 소집 통지(공고)]]></title>
			<link><![CDATA[http://iprotox.co.kr/?kboard_content_redirect=11]]></link>
			<description><![CDATA[<img class="alignnone size-full wp-image-1391" src="http://iprotox.co.kr/wp-content/uploads/2024/12/%EC%BA%A1%EC%B2%98-1.jpg" alt="" width="1200" height="790" />]]></description>
			<author><![CDATA[protox]]></author>
			<pubDate>Thu, 12 Dec 2024 08:21:30 +0000</pubDate>
			<category domain="http://iprotox.co.kr/?kboard_redirect=1"><![CDATA[공지사항]]></category>
		</item>
				<item>
			<title><![CDATA[주주총회 소집 통지(공고)]]></title>
			<link><![CDATA[http://iprotox.co.kr/?kboard_content_redirect=10]]></link>
			<description><![CDATA[<img src="http://iprotox.co.kr/wp-content/uploads/2024/02/%EC%A3%BC%EC%A3%BC%EC%B4%9D%ED%9A%8C-%EC%86%8C%EC%A7%91-%ED%86%B5%EC%A7%80.png" alt="" width="546" height="669" class="alignnone size-full wp-image-1377" />]]></description>
			<author><![CDATA[protox]]></author>
			<pubDate>Mon, 26 Feb 2024 07:40:17 +0000</pubDate>
			<category domain="http://iprotox.co.kr/?kboard_redirect=1"><![CDATA[공지사항]]></category>
		</item>
				<item>
			<title><![CDATA[프로톡신주 생물의약품 품목허가 신청]]></title>
			<link><![CDATA[http://iprotox.co.kr/?kboard_content_redirect=9]]></link>
			<description><![CDATA[1. 품목명 : 프로톡신주

2. 품목허가 신청일 및 허가기관
- 신청일 : 2023년 12월 28일
- 품목허가기관 : 식품의약품안전처(MFDS)]]></description>
			<author><![CDATA[protox]]></author>
			<pubDate>Tue, 02 Jan 2024 05:31:13 +0000</pubDate>
			<category domain="http://iprotox.co.kr/?kboard_redirect=1"><![CDATA[공지사항]]></category>
		</item>
				<item>
			<title><![CDATA[신주발행(제3자배정) 공고]]></title>
			<link><![CDATA[http://iprotox.co.kr/?kboard_content_redirect=8]]></link>
			<description><![CDATA[<img src="http://iprotox.co.kr/wp-content/uploads/kboard_attached/1/202311/65555513cd38b3540369.png" alt="" />]]></description>
			<author><![CDATA[protox]]></author>
			<pubDate>Wed, 15 Nov 2023 23:32:50 +0000</pubDate>
			<category domain="http://iprotox.co.kr/?kboard_redirect=1"><![CDATA[공지사항]]></category>
		</item>
				<item>
			<title><![CDATA[PROTOX homepage has been renewed.]]></title>
			<link><![CDATA[http://iprotox.co.kr/?kboard_content_redirect=7]]></link>
			<description><![CDATA[<h6></h6>
<h6>We have redesigned our website with a new slogan and design
to better communicate PROTOX's R&amp;D, progress, and values to our customers.

PROTOX supports every moment of human, including employees and customers.
Above all, PROTOX holds the value of 'beautiful,' with its origin in 'true to oneself,'
and hopes to contribute together to make every customer's moment the most 'authentically themselves'.</h6>]]></description>
			<author><![CDATA[protox]]></author>
			<pubDate>Tue, 12 Sep 2023 01:09:29 +0000</pubDate>
			<category domain="http://iprotox.co.kr/?kboard_redirect=2"><![CDATA[공지사항-en]]></category>
		</item>
				<item>
			<title><![CDATA[프로톡스 홈페이지 리뉴얼이 완료되었습니다.]]></title>
			<link><![CDATA[http://iprotox.co.kr/?kboard_content_redirect=6]]></link>
			<description><![CDATA[<h6></h6>
<h6>프로톡스의 연구개발과 발전 그리고 가치관을 고객들에게 더 잘 전달하기 위하여
새로운 슬로건과 디자인으로 홈페이지를 개편하였습니다.

프로톡스는 임직원 및 고객 등 전 인류의 모든 순간을 응원하며,
‘나답다’라는 어원을 가진 ‘아름답다’의 가치를 가지고
고객의 모든 순간이 가장 ‘나’다운 순간이 되는 것을 희망하며
함께 이바지 하겠습니다.</h6>
<h6></h6>]]></description>
			<author><![CDATA[protox]]></author>
			<pubDate>Tue, 12 Sep 2023 01:07:41 +0000</pubDate>
			<category domain="http://iprotox.co.kr/?kboard_redirect=1"><![CDATA[공지사항]]></category>
		</item>
			</channel>
</rss>